AzTrials
AzTrials

Premature BirthNCT06731686

Single-center Retrospective Study : Developmental Trajectories of Children Born Prematurely Before 32 Weeks Assessed With the Revised Brunet Lézine Scale at 1, 2 and 3 Years

An observational study of Premature Birth, run by Centre Hospitalier Intercommunal Creteil at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study will assess professionals in the CHI Créteil neonatal department and the Val de Marne perinatal network to gain a better understanding of the developmental trajectories of children hospitalized at the CHI Créteil, with a view to optimizing their care in the long term Read more about this study

Who is it for?
Ages 2 to 32 months
Conditions the study is for
Premature Birth
What is being tested?
Retrospective study
How many people
1,000 participants
Where
1 siteFrance
Study dates
23 Nov 2023to 17 Jun 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 32 months
  • All sexes
  • No healthy volunteers
  • Child

Study population: Children born prematurely before 32 weeks

Who may be able to join

  • Children born at CHI Créteil between 2012 and 2022, included in the Val de Marne perinatal network.
  • Children seen in pediatrician-psychomotor consultation with assessment by the BLR scale at 1 year AC.

Who cannot join

  • Children born with a term of birth ≥ 32 weeks + 1 day.
  • Child removed from the Val de Marne perinatal network monitoring from the age of 1 year AC: Death or parental decision.
  • Children presenting with cerebral palsy, blindness or deafness at the age of 1 year AC.

Trial locations and contacts

1 site in 1 country.

France1 site
  • CHI Créteil

    Créteil, 94000

Other trials in France

About this study

This study will assess professionals in the CHI Créteil neonatal department and the Val de Marne perinatal network to gain a better understanding of the developmental trajectories of children hospitalized at the CHI Créteil, with a view to optimizing their care in the long term

Conditions
Premature Birth
Being tested
Retrospective study
Keywords
Developmental trajectories, Revised Brunet Lézine, movement and posture, language, socialization, coordination
Medical subject headings
Premature Birth, Language

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Retrospective studyOther

    Collection of children's datas

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Overall DQ obtained on the BLR scale at 1, 2 and 3 years, collected by the psychomotor therapists at CHI Créteil.

    Measured: 1, 2 and 3 years

Secondary outcomes (8)
  1. Analysis of the 4 sub-scores (movement and posture, language, socialization, coordination) obtained on the BLR scale at 1, 2 and 3 years, collected by the psychomotor therapists at CHI Créteil.

    Measured: 1,2 and 3 years

  2. Analysis of family socio-demographic data : level of education

    Measured: 1,2 and 3 years

  3. Analysis of family socio-demographic data : age of parents

    Measured: 1,2 and 3 years

  4. Analysis of birth data : term

    Measured: 1, 2 and 3 years

  5. Analysis of birth data : weight

    Measured: 1,2 and 3 years

  6. Analysis of duration of hospitalization

    Measured: 1,2 and 3 years

  7. Evaluate the concordance of BLR scale at 5 years with the measurement scores (not validated) used by the Val de Marne perinatal network (and all the Ile de France perinatal networks) filed out during the same consultations

    Measured: 5 years

  8. Evaluate the concordance of BLR scale at 5 years with the measurement scores (not validated) used by the Val de Marne perinatal network (and all the Ile de France perinatal networks) filed out during the same consultations

    Measured: 1,2 and 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Dec 2024
  2. Study start23 Nov 2023
  3. Primary completion17 Jun 2024
  4. Study completion17 Jun 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
1,000 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06731686
Sponsor's protocol ID
PREMADEV
Status last verified
Dec 2024
First submitted
25 Mar 2024
Last updated
12 Dec 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Premature Birth, run by Centre Hospitalier Intercommunal Creteil at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Overall DQ obtained on the BLR scale at 1, 2 and 3 years, collected by the psychomotor therapists at CHI Créteil. (time frame: 1, 2 and 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Dec 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in